Suppliers / Chongqing Zein Pharmaceutical

Chongqing Zein Pharmaceutical

China 12 employees Updated 9 July 2026

Chongqing Zein Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Orlistat US FDA 1

Also appears on these molecule pages

Orlistat API

Questions about Chongqing Zein Pharmaceutical

Does Chongqing Zein Pharmaceutical hold a US DMF or a CEP?
Chongqing Zein Pharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Chongqing Zein Pharmaceutical make?
1 molecule is on record against Chongqing Zein Pharmaceutical, including Orlistat. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Chongqing Zein Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Biocon shares 1 molecule Formosa Laboratories shares 1 molecule Divi's Laboratories shares 1 molecule Shandong New Time Pharmaceutical shares 1 molecule Murli Krishna Pharma shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability